UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.931

Sortiert nach

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Clinical pharmacology and therapeutics, 2017-03, Vol.101 (3), p.341-358

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of water content on the glass transition temperature of mixtures of sugars, polymers, and penetrating cryoprotectants in physiological buffer

PloS one, 2018-01, Vol.13 (1), p.e0190713-e0190713

2018

Link zum Volltext

Verfügbarkeit prüfen

Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose

CPT: pharmacometrics and systems pharmacology, 2013-06, Vol.2 (6), p.1-9

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnosing Model Diagnostics

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.17-20

2007

Link zum Volltext

Verfügbarkeit prüfen

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin

Clinical pharmacology and therapeutics, 2008-07, Vol.84 (1), p.52-62

2008

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Bedaquiline and Metabolite M2 in Patients With Drug‐Resistant Tuberculosis: The Effect of Time‐Varying Weight and Albumin

CPT: pharmacometrics and systems pharmacology, 2016-12, Vol.5 (12), p.682-691

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials

Journal of clinical pharmacology, 2018-10, Vol.58 (10), p.1284-1294

2018

Link zum Volltext

Verfügbarkeit prüfen

No evidence of an association between size and levels of four per- and polyfluorinated substances (PFAS) in perch (Perca fluviatilis)

The Science of the total environment, 2024-07, Vol.934, p.173124, Article 173124

2024

Link zum Volltext

Verfügbarkeit prüfen

Xpose : an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

Computer methods and programs in biomedicine, 1999, Vol.58 (1), p.51-64

1999

Link zum Volltext

Verfügbarkeit prüfen

A Pharmacodynamic Markov Mixed-Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis

Clinical pharmacology and therapeutics, 2009-10, Vol.86 (4), p.387-395

2009

Link zum Volltext

Verfügbarkeit prüfen

FTIR Analysis of Molecular Changes Associated with Warming Injury in Cryopreserved Leukocytes

Langmuir, 2019-06, Vol.35 (23), p.7552-7559

2019

Link zum Volltext

Verfügbarkeit prüfen

Phosphorus release from coastal Baltic Sea sediments as estimated from sediment profiles

Estuarine, coastal and shelf science, 2011-03, Vol.92 (1), p.111-117

2011

Link zum Volltext

Verfügbarkeit prüfen

Protein–Water–Ice Contact Angle

Langmuir, 2019-06, Vol.35 (23), p.7383-7387

2019

Link zum Volltext

Verfügbarkeit prüfen

Model averaging for robust assessment of QT prolongation by concentration‐response analysis

Statistics in medicine, 2017-10, Vol.36 (24), p.3844-3857

2017

Link zum Volltext

Verfügbarkeit prüfen

A model-based longitudinal meta-analysis of FEV1 in randomized COPD trials

Clinical pharmacology and therapeutics, 2016-03, Vol.99 (3), p.315-324

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model‐Based Drug Development

CPT: pharmacometrics and systems pharmacology, 2013-03, Vol.2 (3), p.1-3

2013

Link zum Volltext

Verfügbarkeit prüfen

Approaches to Simultaneous Analysis of Frequency and Severity of Symptoms

Clinical pharmacology and therapeutics, 2010-08, Vol.88 (2), p.255-259

2010

Link zum Volltext

Verfügbarkeit prüfen

Modeling and Simulation of the Time Course of Asenapine Exposure Response and Dropout Patterns in Acute Schizophrenia

Clinical pharmacology and therapeutics, 2009-07, Vol.86 (1), p.84-91

2009

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic Modeling of a Magnetic Marker Monitoring Study Linking Gastrointestinal Tablet Transit, In Vivo Drug Release, and Pharmacokinetics

Clinical pharmacology and therapeutics, 2009-07, Vol.86 (1), p.77-83

2009

Link zum Volltext

Verfügbarkeit prüfen

Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients

Cancer chemotherapy and pharmacology, 2006-08, Vol.58 (2), p.143-156

2006

Link zum Volltext

Verfügbarkeit prüfen

Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children

European journal of clinical pharmacology, 2012-04, Vol.68 (4), p.339-347

2012

Link zum Volltext

Verfügbarkeit prüfen

Automated covariate model building within NONMEM

Pharmaceutical research, 1998-09, Vol.15 (9), p.1463-1468

1998

Link zum Volltext

Verfügbarkeit prüfen

Estimating costs and potentials of different methods to reduce the Swedish phosphorus load from agriculture to surface water

The Science of the total environment, 2010, Vol.408 (3), p.473-479

2010

Link zum Volltext

Verfügbarkeit prüfen

Model Describing the Relationship Between Pharmacokinetics and Hematologic Toxicity of the Epirubicin-Docetaxel Regimen in Breast Cancer Patients

Journal of clinical oncology, 2005-01, Vol.23 (3), p.413-421

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.931

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.708)
Mit Volltextzugriff
(1.787)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Effect of water content on the glass transition temperature of mixtures of sugars, polymers, and penetrating cryoprotectants in physiological buffer

Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose

Diagnosing Model Diagnostics

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin

Population Pharmacokinetics of Bedaquiline and Metabolite M2 in Patients With Drug‐Resistant Tuberculosis: The Effect of Time‐Varying Weight and Albumin

Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials

No evidence of an association between size and levels of four per- and polyfluorinated substances (PFAS) in perch (Perca fluviatilis)

Xpose : an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

A Pharmacodynamic Markov Mixed-Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis

FTIR Analysis of Molecular Changes Associated with Warming Injury in Cryopreserved Leukocytes

Phosphorus release from coastal Baltic Sea sediments as estimated from sediment profiles

Protein–Water–Ice Contact Angle

Model averaging for robust assessment of QT prolongation by concentration‐response analysis

A model-based longitudinal meta-analysis of FEV1 in randomized COPD trials

Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model‐Based Drug Development

Approaches to Simultaneous Analysis of Frequency and Severity of Symptoms

Modeling and Simulation of the Time Course of Asenapine Exposure Response and Dropout Patterns in Acute Schizophrenia

Mechanistic Modeling of a Magnetic Marker Monitoring Study Linking Gastrointestinal Tablet Transit, In Vivo Drug Release, and Pharmacokinetics

Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients

Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children

Automated covariate model building within NONMEM

Estimating costs and potentials of different methods to reduce the Swedish phosphorus load from agriculture to surface water

Model Describing the Relationship Between Pharmacokinetics and Hematologic Toxicity of the Epirubicin-Docetaxel Regimen in Breast Cancer Patients

Suchergebnisse filtern